Rosas I., Morís G., Coto E., Blázquez-Estrada M., Suárez E., García-Fernández C., Martínez C., Herrera I.D., Pérez-Oliveira S., Álvarez V., Menéndez-González M., Adarmes-Gómez A.D., Aguilar M., Alvarez I., Barrero F.J., Bergareche Yarza J.A., Bonilla-Toribio M., Botía J.A., Boungiorno M.T., Buiza-Rueda D., Cámara A., Carrillo F., Cerdan D., Clarimón J., Compta Y., Diez-Fairen M., Dols-Icardo O., de Fabregues O., Cartagena P.S., Duarte J., Duran R., Escamilla-Sevilla F., Ezquerra M., Feliz C., Fernández-Santiago R., Fernández M., García-Ruiz P., Gómez-Garre P., Gomez Heredia M.J., Gonzalez-Aramburu I., Gorostidi A., Hoenicka J., Infante J., Jesús S., Jimenez-Escrig A., Kulisevsky J., Labrador-Espinosa M.A., Lopez-Sendon J.L., López de Munain A., Macias-Garcia D., Martínez-Torres I., Marín J., Marti M.J., Martínez-Castrillo J.C., Álvarez-Santullano M.M., Mínguez-Castellanos A., Mir P., Rezola E.M., Muñoz E., Pagonabarraga J., Pastor P., Errazquin F.P., Periñán M.T., Ruiz-Martínez J., Ruz C., Rodriguez A.S., Sierra M., Tabernero C., Tartari J.P., Tolosa E., Valldeoriola F., Vela L., Vives F., Pascual-Sedano B., Hernández-Vara J., Rolán D.V., Bandrés-Ciga S.. Smoking is associated with age at disease onset in Parkinson's disease. PARKINSONISM & RELATED DISORDERS. 2022; 97DOI:10.1016/j.parkreldis.2022.03.005. PMID:35364453. IF:4.100(Q2/3D).

Puerta, R, de Rojas, I, García-González, P, Olivé, C, Sotolongo-Grau, O, García-Sánchez, A, García-Gutiérrez, F, Montrreal, L, Tartari, JP, Sanabria, A, Pytel, V, Lage, C, Quintela, I, Aguilera, N, Rodriguez-Rodriguez, E, Alarcón-Martín, E, Orellana, A, Pastor, P, Pérez-Tur, J, Piñol-Ripoll, G, de Munain, AL, García-Alberca, JM, Royo, JL, Bullido, MJ, Alvarez, V, Real, LM, Anchuelo, AC, Gómez-Garre, D, Larrad, MTM, Franco-Macías, E, Mir, P, Medina, M, Sánchez-Valle, R, Dols-Icardo, O, Sáez, ME, Carracedo, A, Tárraga, L, Alegret, M, Valero, S, Marquié, M, Boada, M, Juan, PS, Cavazos, JE, Cabrera-Socorro, A, Cano, A, Ruiz, A, Alzheimers Dis Neuroimaging Initiative. Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO. FUNCTIONAL & INTEGRATIVE GENOMICS. 2025; 25(1)DOI:10.1007/s10142-025-01581-6. PMID:40133566. IF:3.100(Q2/4D).

Sauter, C, Dorn, H, Bueno-Lopez, A, Eggert, T, Schmid, G, Danker-Hopfe, H. Effects of radiofrequency electromagnetic fields on cognitive function in elderly subjects (60+years)-Results of an experimental randomized sham controlled double-blind cross-over study in women and in men. ENVIRONMENTAL RESEARCH. 2025; 285DOI:10.1016/j.envres.2025.122479. PMID:40744201. IF:7.700(Q1/1D).

Fortea, J, Ferrer-Picón, E. An overview of the rivastigmine 13.3 mg/24h transdermal patch as a treatment option for Alzheimer's disease. Expert Review of Neurotherapeutics. 2025; 25(9)DOI:10.1080/14737175.2025.2527211. PMID:40600688. IF:3.400(Q2/3D).

Querol, CB, Canyelles, M, Santos, D, Martínez, J, Mercer, A, Zhao, Q, Rotllan, N, Núñez, E, Vázquez, J, Maspoch, D, Cano-Sarabia, M, Carmona-Iragui, M, Sirisi, S, Lleó, A, Fortea, J, Alcolea, D, Blanco-Vaca, F, Escolà-Gil, JC, Tondo, M. Impaired cerebrospinal fluid lipoprotein-mediated cholesterol transport in Alzheimer's disease. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).

Oosthoek, M, Vijverberg, EGB, Blujdea, ER, Veld, SGJGI, Avilés, MP, Zsadanyi, SE, Hok-A-Hin, YS, Visser, A, van der Flier, WM, Barkhof, F, del Campo, M, Schut, MC, Bejanin, A, Alcolea, D, Teunissen, CE, Vermunt, L. CHIT1 and DDAH1 levels relate to amyloid-related imaging abnormalities risk profile in Alzheimer's disease patients. Alzheimers Research & Therapy. 2025; 17(1)DOI:10.1186/s13195-025-01799-3. PMID:40696469. IF:7.600(Q1/1D).